Israel’s BrainStorm Cell Therapeutics has reported that final results of its clinical trial conducted at the Hadassah Medical Center using adult stem cells to treat amyotrophic lateral sclerosis (ALS) indicate that most patients experienced a slowing of their disease’s progression.